MF Researcher Database

Researcher Database

Advance

Honda Hirokazu

■FacultyNephrology
■PositionProfessor
Last Updated :2025/04/01

Researcher

基本情報

Profile and Settings

  • 氏名

    Honda Hirokazu

Affiliation

  • Nephrology, Professor

Location

  • University Hospital

Degree

  • Doctor of Medical Science, Showa University, Feb. 2004

Achievements

Published Papers

  • Changes in Sequential Organ Failure Assessment sub-scores as predictors of mortality in patients with septic acute kidney injury requiring continuous renal replacement therapy, ABE Maki;IKEDA-TANIGUCHI Misa;HONDA Hirokazu, Showa Univ J Med Sci, 34(3):159 - 175, Sep. 2022, Peer-reviewed, DOI:https://doi.org/10.15369/sujms.34.159
  • A case of acute poststreptococcal glomerulonephritis complicated by interstitial nephritis related to streptococcal pyrogenic exotoxin B., KANAZAWA Nobuhiro;IYODA Masayuki;HAYASHI Junichi;HONDA Kazuho;ODA Takashi;HONDA Hirokazu, Pathol Int, 72(3):200 - 206, Mar. 2022, Peer-reviewed
  • Association between the use of exchange devices for peritoneal dialysis fluids and peritonitis incidence: A nationwide cohort study., Hasegawa T, Noma H, Hamano T, Abe M, Wada A, Honda H, Ito Y, Masakane I, Nitta K., Perit Dial Int, 42(2):177 - 184, Mar. 2022, Peer-reviewed, DOI:10.1177/08968608211051591
  • Severe acyclovir-induced encephalopathy in an elderly patient with herpes zoster., NAKAJIMA Kota;MOMO Kenji;NIMURA Satomi;KAIZAKI-MITSUMOTO Asuka;KANAZAWA Nobuhiro;INABA Taro;SAITO Tomohiro;WADA Yukihiro;HONDA Hirokazu;NUMAZAWA Satoshi;SASAKI Tadanori, Eur J Clin Pharmacol, 78(3):527 - 529, Mar. 2022, Peer-reviewed, DOI:10.1007/s00228-021-03243-5
  • Time-dependent changes in serum concentrations of acyclovir and its metabolite, 9-carboxymethoxymethylguanine, in a patient with suspected acyclovir encephalopathy suspected acyclovir encephalopathy, ABE Kazumasa;KAIZAKI-MITSUMOTO Asuka;SAITO Tomohiro;SUGIYAMA Motonori;HONDA Hirokazu;NUMAZAWA Satoshi, Fundam Toxicol Sci, 8(7):229 - 233, Dec. 2021, Peer-reviewed
  • Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients, Yasuto Shikida; Masahide Mizobuchi; Osamu Yoshitake; Tadashi Kato; Hiroaki Ogata; Fumihiko Koiwa; Hirokazu Honda, THERAPEUTIC APHERESIS AND DIALYSIS, 25(3):331 - 340, Jun. 2021, Peer-reviewed, DOI:10.1111/1744-9987.13578
  • Anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series., SAITO Tomohiro;MIZOBUCHI Masahide;MIWA Yusuke;SUGIYAMA Motonori;MIMA Yuuki;IIDA Ayana;KANAZAWA Nobuhiro;MORIKAWA Tomoki;HAYASHI Junichi;FUKUDA Kei;SHIKIDA Yasuto;SUZUKI Taihei;HONDA Hirokazu, J Clin Apher, 36(1):196 - 205, Feb. 2021, Peer-reviewed
  • 慢性腎臓病（CKD）患者の脂質異常, 本田　浩一, 昭和学士会雑誌, 80(6):478 - 484, Jan. 2021, Peer-reviewed
  • Osteoblastic differentiation of bone marrow mesenchymal stem cells in uremic rats., KATO Tadashi;MIZOBUCHI Masahide;SASA Kiyohito;YAMADA Atsushi;OGATA Hiroaki;HONDA Hirokazu;SAKASHITA Akiko;KAMIJO Ryutaro, Biochem Biophys Res Commun, 532(1):11 - 18, Oct. 2020, Peer-reviewed
  • A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy., SUGIYAMA Motonori;WADA Yukihiro;KANAZAWA Nobuhiro;TACHIBANA Shohei;SUZUKI Taihei;MATSUMOTO Kei;IYODA Masayuki;HONDA Hirokazu;SHIBATA Takanori, PloS One, 15(4):e0232194, Apr. 2020, Peer-reviewed
  • Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis., HONDA Hirokazu;HIRANO Tsutomu;UEDA Masashi;KOJIMA Shiho;MASHIBA Shinichi;HAYASE Yasuyuki;MICHIHATA Tetsuo;SHISHIDO Kanji;TAKAHASHI Keiko;HOSAKA Nozomu;IKEDA Misa;SANADA Daisuke;SHIBATA Takanori, PloS One, 12(5):e0177980, May 2017, Peer-reviewed
  • High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients., HONDA Hirokazu;MICHIHATA Tetsuo;SHISHIDO Kanji;TAKAHASHI Keiko;TAKAHASHI Go;HOSAKA Nozomu;IKEDA Misa;SANADA Daisuke;SHIBATA Takanori, PloS One, 12(5):e0176984, May 2017, Peer-reviewed
  • Membranous glomerulonephropathy in a patient with bullous pemphigoid., IKEDA Misa;HONDA Hirokazu;KOBAYASHI Naoki;ONUMA Shoko;MATSUMOTO Kei;AKIZAWA Tadao;YAMAGUCHI Yutaka ;SHIBATA Takanori, CEN Case Rep, 6(1):50 - 54, May 2017, Peer-reviewed
  • N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients., IKEDA Misa;HONDA Hirokazu;TAKAHASHI Keiko;SHISHIDO Kanji;SHIBATA Takanori, PloS One, 11(11):e0166804, Nov. 2016, Peer-reviewed
  • Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis., HONDA Hirokazu;KOBAYASHI Yasuna;ONUMA Shoko;SHIBAGAKI Keigo;YUZA Toshitaka;HIRAO Keiichi;YAMAMOTO Toshinori;TOMOSUGI Naohisa;SHIBATA Takanori, PloS One, 11(3):e0151601, Mar. 2016, Peer-reviewed
  • High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease., HONDA Hirokazu;HIRANO Tsutomu;UEDA Masashi;KOJIMA Shiho;MASHIBA Shinichi;HAYASE Yasuyuki;MICHIHATA Tetsuo;SHIBATA Takanori, J Atheroscler Thromb, 23(1):81 - 94, Jan. 2016, Peer-reviewed
  • Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis, ONUMA Shoko;HONDA Hirokazu;KOBAYASHI Yasuna;YAMAMOTO Toshinori;MICHIHATA Tetsuo;SHIBAGAKI Keigo;YUZA Toshitaka;HIRAO Keiichi;TOMOSUGI Naohisa ;SHIBATA Takanori, Ther Apher Dial, 19(6):582 - 589, Oct. 2015, Peer-reviewed
  • Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis., ARITA OKUBO Shigeko;KIM KANEYAMA Joo-ri;LEI Xiao-Feng;FU Wen-Guang;OHNISHI Koji;TAKEYA Motohiro;MIYAUCHI Aya;HONDA Hirokazu;ITABE Hiroyuki;MIYAZAKI Takuro;MIYAZAKI Akira, Cardiovasc Res, 105(3):361 - 371, Mar. 2015, Peer-reviewed, DOI:10.1093/cvr/cvv003
  • Associations among epoetin therapy, inflammation, nutritional status, and mortality in patients on hemodialysis., HONDA Hirokazu;KIMATA Naoki;WAKUI Kenji;AKIZAWA Tadao, J Ren Nutr, 24(5):322 - 329, Sep. 2014, Peer-reviewed
  • Active vitamin D analogs, maxacalcitol and alfacalcidol, as maintenance therapy for mild secondary hyperparathyroidism in hemodialysis patients - a randomized study., HONDA Hirokazu;KOIWA Fumihiko;OGATA Hiroaki;SHISHIDO Kanji;SEKIGUCHI Takashi;MICHIHATA Tetsuo;OGAWA Hajime;MUKAI Masanori;TAKAHASHI Keiko;SUZUKI Ryuji;KINO Kyoko;KATO Kenichi;YAMAMOTO Koji;KINUGASA Eriko;AKIZAWA Tadao, Int J Clin Pharmacol Ther, 52(5):360 - 368, May 2014, Peer-reviewed
  • Effect of renal impairment on the pharmacokinetics of memantine., MORITOYO Takashi;HASUNUMA Tomoko;HARADA Kazuhiro;TATEISHI Tomonori;WATANABE Makoto;KOTEGAWA Tsutomu;NAGAI Masahiro;KUMAGAI Yuji;FUJITANI Tomomichi;OKURA Takahumi;FUKUOKA Tomikazu;MIYOSHI Kenichi;MATSUURA Bunzo;FURUKAWA Shinya;KOBORI Tomoe;MORITOYO Hiroyoko;NISHIKAWA Noriko;TSUJIi Tomoaki;IWAKI Hirotaka;NAKAMURA Masahiko;MAKINO Satoshi;OHMURA Kei;YUJI Koichiro;HASHIMOTO Megumi;TAKASU Masaru;HASHIZUME Yutaka;YOU Koji;MATSUMURA Tomoko;TANAKA Yuji;MATSUMOTO Nahoko;NAKAMURA Junichi;MIURA Jun;AKIZAWA Tadao;KITAZAWA Kozo;SHIBATA Takanori;KUROKI Aki;HONDA Hirokazu;MUKAI Masanori;OHASHI Kyoichi;MORIMOTO Takuya;IMAI Hiromitsu;OKUDAIRA Toshiaki;SATO Fuminori;IMANAGA Junko;TANAKA Katsuhiro;NOMOTO Masahiro, J Pharmacol Sci, 119(4):324 - 329, Aug. 2012, Peer-reviewed
  • 慢性腎臓病と酸化HDL、酸化HDLサブフラクションとの関係, 本田　浩一;平野　勉;道端　哲郎;上田　昌伺;小嶌　志穂;真柴　新一;早瀬　泰行;小椋　陽介;秋澤　忠男, Ther Res, 33(8):1164 - 1166, Aug. 2012
  • Granulomatous interstitial nephritis in a renal allograft, NUNOTA Noriko;HONDA Hirokazu;SHIBATA Takanori;YOSHITAKE Osamu;MURAKAMI Masahiko;SANADA Daisuke;YOKOCHI Akio;KATO Noriyuki;KUROKI Aki;HONDA Kazuho;YAMAGUCHI Yutaka;SUGISAKI Tetsuzo;AKIZAWA Tadao, CEN Case Rep, 1(1):12 - 15, May 2012, Peer-reviewed
  • Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients., HONDA Hirokazu;UEDA Masashi;KOJIMA Shiho;MASHIBA Shinichi;MICHIHATA Tetsuo;TAKAHASHI Keiko;SHISHIDO Kanji;AKIZAWA Tadao, Atherosclerosis, 220(2):493 - 501, Feb. 2012, Peer-reviewed
  • Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients, HONDA Hirokazu;HOSAKA Nozomu;AOSHIMA Yumie;HIRAI Yuki;MICHIHATA Tetsuo;AKIZAWA Tadao, Clin Exp Hypertens, 34(1):17 - 23, Dec. 2011, Peer-reviewed
  • 移植腎に肉芽腫性間質性病変を発症した症例, 布田　典子;本田　浩一;柴田　孝則;加藤　徳介;真田　大介;青嶋　弓恵;横地　章生;黒木　亜紀;吉武　理;村上　雅彦;秋澤　忠男, 腎と透析, 71(6):879 - 885, Dec. 2011
  • Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis, SUZUKI Ruji;HONDA Hirokazu;NIIKURA Kazuhiko;AKIZAWA Tadao, Clin Exp Hypertens, 34(2):125 - 131, Oct. 2011, Peer-reviewed
  • Assessment of inflow of endotoxin and its fragments in patients on maintenance hemodialysis., SUZUKI Hiroki;HONDA Hirokazu;KATO Noriyuki;MICHIHATA Tetsuo;TAKAHASHI Keiko;SHISHIDO Kanji;AKIZAWA Tadao, Blood Purif, 31(4):268 - 275, Jun. 2011, Peer-reviewed
  • Serum Paraoxonase 1 (PON1) Concentration as a Marker of Left Ventricular Mass Index (LVMI) and Atherosclerosis in Hemodialysis Patients, MATSUMOTO Kei;WATANABE Makoto;OMORI Maho;HONDA Hirokazu;HATTORI Hiroaki;AKIZAWA Tadao, Showa Univ J Med Sci, 22(4):199 - 209, Dec. 2010, Peer-reviewed, DOI:10.15369/sujms.22.199
  • Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients, ASHIKAGA Eijin;HONDA Hirokazu;SUZUKI Hiroki;HOSAKA Nozomu;HIRAI Yuki;SANADA Daisuke;NAKAMURA Mari;NAGAI Hisako;MATSUMOTO Kei;KATO Norayuki;MUKAI Masanori;WATANABE Makoto;TAKAHASHI Keiko;SHISHIDO Kanji;AKIZAWA Tadao, Ther Apher Dial., 14(3):315 - 322, Jun. 2010, Peer-reviewed
  • Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients., OMORI Maho;WATANABE Makoto;MATSUMOTO Kei;HONDA Hirokazu;HATTORI Hiroaki;AKIZAWA Tadao, Ther Apher Dial, 14(3):341 - 348, Jun. 2010, Peer-reviewed
  • Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients, HONDA Hirokazu;UEDA Masashi;KOJIMA Shiho;MASHIBA Shinichi;SUZUKI Hiroki;HOSAKA Nozomu;HIRAI Yuki;NAKAMURA Mari;NAGAI Hisako;KATO Noriyuki;MUKAI Masanori;WATANABE Makoto;TAKAHASHI Keiko;SHISHIDO Kanji;AKIZAWA Tadao, Clin J Am Soc Nephrol, 5(6):1021 - 1028, Jun. 2010, Peer-reviewed
  • CKDガイドラインからみた食事療法, 本田　浩一;秋澤　忠男, 昭和医学会雑誌, 70(2):126 - 130, Apr. 2010, Peer-reviewed, DOI:10.14930/jsma.70.126

Presentations

  • 糸球体腎炎における単離した近位尿細管のプロテオーム解析の検討, 康 徳東;下川 麻由;河西 恵州;澤 智華;相内 敏弘;髙木 孝士;板部 洋之;矢持 淑子;本田 浩一;川西 邦夫;本田 一穂, 第67回日本腎臓学会学術総会, 29 Jun. 2024
  • エボカルセトの,二次性副甲状腺機能亢進症モデルラットのカルシウム感知受容体とビタミンD受容体への影響, 齋藤 友広;溝渕 正英;酒井 まり子;川田 剛央;北山 哲也;加藤 憲;鈴木 泰平;緒方 浩顕;小岩 文彦;本田 浩一, 第66回日本腎臓学会学術総会, 09 Jun. 2023, 横浜
  • 腎機能の回復に時間を要した覚醒剤常習者の1例, 吉田　峻祐;柿　佑樹;式田　康人;原野　康平;杉本　達也;井上　元;中島　靖浩;加藤　晶人;森川　健太郎;本田　浩一;土肥　謙二, 第48回日本救急医学会総会学術集会, 18 Nov. 2020, 岐阜・オンデマンド配信
  • 小腸膀胱瘻を伴い著明な高クロール性代謝性アシドーシスを呈した巨大膀胱結石による腎後性腎不全の一例, 松本　啓;美馬　友紀;及川　愛;宮崎　友晃;小川　祐;山本　真寛;伊藤　英利;深貝　隆志;本田　浩一, 第50回日本腎臓学会東部学術大会, 26 Sep. 2020, LIVE配信
  • T cell mediated rejection in a kidney transplant recipient after administration of anti-tuberculous drugs, 金澤　伸洋;伊與田　雅之;吉武　理;本田　一穂;本田　浩一, 第50回日本腎臓学会東部学術大会, 26 Sep. 2020, LIVE配信
  • A case of post-streptococcal acute glomerulonephritis complicated by interstitial nephritis, 金澤　伸洋;伊與田　雅之;福田　桂;林　純一;本田　一穂;本田　浩一, 第50回日本腎臓学会東部学術大会, 26 Sep. 2020, LIVE配信
  • 走査電子顕微鏡(SEM)を用いた透過電子顕微鏡(TEM)切片観察の可能性とその利点, 髙木　孝士;坂上　万里;康　德東;金澤　伸洋;南雲　佑;向井　俊平;本田　浩一;瀧本　雅文;本田　一穂, 第63回日本腎臓学会学術総会, 21 Aug. 2020, 誌上開催
  • 東レ社製ポリスルホン(PS)膜血液透析濾過器NVFの循環動態に対する臨床評価, 森本　嘉純;永里　美菜;森田　拓;野村　美歩;太鼓　千恵;坂本　圭三;西堀　英城;大石　竜;本田　浩一, 第46回日本血液浄化技術学会学術大会・総会, 21 Apr. 2019, 東京
  • 慢性腎臓病患者の貧血と造血過程の鉄代謝関連因子の挙動, 本田　浩一, 第42回日本鉄バイオサイエンス学会学術集会, 01 Sep. 2018, 内灘町
  • 東レ社製ポリスルホン(PS)膜血液透析濾過器NVFの循環動態に対する臨床評価, 森本　嘉純;永里　美菜;中林　優子;太鼓　千恵;坂本　圭三;西山　謙一;本田　浩一, 第63回日本透析医学会学術集会・総会, 30 Jun. 2018, 神戸
  • 血液透析患者の造血・鉄代謝 -ESA療法に伴うエリスロフェロンとヘプシジン25の挙動-, 本田　浩一, 第63回日本透析医学会学術集会・総会, 29 Jun. 2018, 神戸
  • 血液透析患者における後天的Klotho遺伝子変性について, 本田　浩一;小林　靖奈;有賀　誠記;上竹　大二郎 ;柴田　孝則, 第61回日本腎臓学会学術総会, 08 Jun. 2018, 新潟
  • Monoclonal IgA-λ型によるIgA血管炎の一例, 高橋　剛;保坂　望;本田　浩一;福田　桂;丸田　雄一;伊與田　雅之;九島　巳樹;本田　一穂;柴田　孝則, 第47回日本腎臓学会東部学術大会, 28 Oct. 2017, 横浜
  • 治療目標Hb値とESA投与方法, 本田　浩一, 第62回日本透析医学会学術集会・総会, 17 Jun. 2017, 横浜
  • Erythroferrone-ESAとhepcidin25, 本田　浩一, 第62回日本透析医学会学術集会・総会, 16 Jun. 2017, 横浜
  • Endotoxin Activity Assay(EAA)を用いた清浄化透析液の検討, 上原　克也;脇坂　沙季;永里　美菜;村上　織恵;柿沼　浩;本田　浩一;柴田　孝則, 第43回東京透析懇談会, 22 Feb. 2015, 東京
  • 単クローン性IgAの沈着を伴う半月体形成性糸球体腎炎の一例, 眞田　大介;伊與田　雅之;井芹　健;池田　美紗;冨田　瑛子;齋藤　友広;本田　浩一;山口　裕;柴田　孝則, 第44回日本腎臓学会東部学術大会, 25 Oct. 2014, 東京

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.